Literature DB >> 21795348

Circulating monocytes are not a major reservoir of HIV-1 in elite suppressors.

Adam M Spivak1, Maria Salgado, S Alireza Rabi, Karen A O'Connell, Joel N Blankson.   

Abstract

Circulating HIV-1-infected monocytes have been identified in patients on highly active antiretroviral therapy and may represent an important barrier to viral eradication. The nature of these cells in HIV-1-infected patients who maintain undetectable viral loads and preserved CD4(+) T cell counts without antiretroviral therapy (known as elite controllers or elite suppressors [ES]) is unknown. We describe here infrequent recovery of proviral HIV-1 DNA from circulating monocytes relative to CD4(+) T cells in ES, despite permissiveness of these cells to HIV-1 viral entry ex vivo. Thus, monocytes do not appear to be a major reservoir of HIV-1 in ES.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21795348      PMCID: PMC3196433          DOI: 10.1128/JVI.05409-11

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  61 in total

1.  Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy.

Authors:  D Finzi; J Blankson; J D Siliciano; J B Margolick; K Chadwick; T Pierson; K Smith; J Lisziewicz; F Lori; C Flexner; T C Quinn; R E Chaisson; E Rosenberg; B Walker; S Gange; J Gallant; R F Siliciano
Journal:  Nat Med       Date:  1999-05       Impact factor: 53.440

2.  Persistence of distinct HIV-1 populations in blood monocytes and naive and memory CD4 T cells during prolonged suppressive HAART.

Authors:  Pierre Delobel; Karine Sandres-Sauné; Michelle Cazabat; Fatima-Ezzahra L'Faqihi; Christian Aquilina; Martine Obadia; Christophe Pasquier; Bruno Marchou; Patrice Massip; Jacques Izopet
Journal:  AIDS       Date:  2005-11-04       Impact factor: 4.177

3.  Neutralizing antibodies do not mediate suppression of human immunodeficiency virus type 1 in elite suppressors or selection of plasma virus variants in patients on highly active antiretroviral therapy.

Authors:  Justin R Bailey; Kara G Lassen; Hung-Chih Yang; Thomas C Quinn; Stuart C Ray; Joel N Blankson; Robert F Siliciano
Journal:  J Virol       Date:  2006-05       Impact factor: 5.103

4.  Residual human immunodeficiency virus type 1 viremia in some patients on antiretroviral therapy is dominated by a small number of invariant clones rarely found in circulating CD4+ T cells.

Authors:  Justin R Bailey; Ahmad R Sedaghat; Tara Kieffer; Timothy Brennan; Patricia K Lee; Megan Wind-Rotolo; Christine M Haggerty; Ashrit R Kamireddi; Yi Liu; Jessica Lee; Deborah Persaud; Joel E Gallant; Joseph Cofrancesco; Thomas C Quinn; Claus O Wilke; Stuart C Ray; Janet D Siliciano; Richard E Nettles; Robert F Siliciano
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

5.  HIV controllers: a homogeneous group of HIV-1-infected patients with spontaneous control of viral replication.

Authors:  Olivier Lambotte; Faroudy Boufassa; Yoann Madec; Ahn Nguyen; Cécile Goujard; Laurence Meyer; Christine Rouzioux; Alain Venet; Jean-François Delfraissy
Journal:  Clin Infect Dis       Date:  2005-08-30       Impact factor: 9.079

6.  Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy.

Authors:  D Finzi; M Hermankova; T Pierson; L M Carruth; C Buck; R E Chaisson; T C Quinn; K Chadwick; J Margolick; R Brookmeyer; J Gallant; M Markowitz; D D Ho; D D Richman; R F Siliciano
Journal:  Science       Date:  1997-11-14       Impact factor: 47.728

Review 7.  Migratory fate and differentiation of blood monocyte subsets.

Authors:  Frank Tacke; Gwendalyn J Randolph
Journal:  Immunobiology       Date:  2006-07-10       Impact factor: 3.144

8.  Isolation and characterization of replication-competent human immunodeficiency virus type 1 from a subset of elite suppressors.

Authors:  Joel N Blankson; Justin R Bailey; Seema Thayil; Hung-Chih Yang; Kara Lassen; Jun Lai; Shiv K Gandhi; Janet D Siliciano; Thomas M Williams; Robert F Siliciano
Journal:  J Virol       Date:  2006-12-06       Impact factor: 5.103

9.  CCR5 expression correlates with susceptibility of maturing monocytes to human immunodeficiency virus type 1 infection.

Authors:  H M Naif; S Li; M Alali; A Sloane; L Wu; M Kelly; G Lynch; A Lloyd; A L Cunningham
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

10.  Maintenance of viral suppression in HIV-1-infected HLA-B*57+ elite suppressors despite CTL escape mutations.

Authors:  Justin R Bailey; Thomas M Williams; Robert F Siliciano; Joel N Blankson
Journal:  J Exp Med       Date:  2006-05-08       Impact factor: 14.307

View more
  15 in total

Review 1.  HIV-1 target cells in the CNS.

Authors:  Sarah B Joseph; Kathryn T Arrildt; Christa B Sturdevant; Ronald Swanstrom
Journal:  J Neurovirol       Date:  2014-09-19       Impact factor: 2.643

2.  Antiretroviral monocyte efficacy score linked to cognitive impairment in HIV.

Authors:  Cecilia M Shikuma; Beau Nakamoto; Bruce Shiramizu; Chin-Yuan Liang; Victor DeGruttola; Kara Bennett; Robert Paul; Kalpana Kallianpur; Dominic Chow; Christina Gavegnano; Selwyn J Hurwitz; Raymond F Schinazi; Victor G Valcour
Journal:  Antivir Ther       Date:  2012-09-28

3.  Macrophages sustain HIV replication in vivo independently of T cells.

Authors:  Jenna B Honeycutt; Angela Wahl; Caroline Baker; Rae Ann Spagnuolo; John Foster; Oksana Zakharova; Stephen Wietgrefe; Carolina Caro-Vegas; Victoria Madden; Garrett Sharpe; Ashley T Haase; Joseph J Eron; J Victor Garcia
Journal:  J Clin Invest       Date:  2016-03-07       Impact factor: 14.808

Review 4.  The implications of viral reservoirs on the elite control of HIV-1 infection.

Authors:  Robert W Buckheit; Maria Salgado; Karen O Martins; Joel N Blankson
Journal:  Cell Mol Life Sci       Date:  2012-08-04       Impact factor: 9.261

5.  Relationships of PBMC microRNA expression, plasma viral load, and CD4+ T-cell count in HIV-1-infected elite suppressors and viremic patients.

Authors:  Kenneth W Witwer; Andria K Watson; Joel N Blankson; Janice E Clements
Journal:  Retrovirology       Date:  2012-01-12       Impact factor: 4.602

6.  The Impact of Macrophage Nucleotide Pools on HIV-1 Reverse Transcription, Viral Replication, and the Development of Novel Antiviral Agents.

Authors:  Christina Gavegnano; Edward M Kennedy; Baek Kim; Raymond F Schinazi
Journal:  Mol Biol Int       Date:  2012-07-01

7.  Intracellular overexpression of HIV-1 Nef impairs differentiation and maturation of monocytic precursors towards dendritic cells.

Authors:  Yan Guo; Wen-Wen Xu; Jie Song; Wen Deng; Di-Qiu Liu; Hua-Tang Zhang
Journal:  PLoS One       Date:  2012-07-09       Impact factor: 3.240

8.  Differential levels of soluble inflammatory markers by human immunodeficiency virus controller status and demographics.

Authors:  Jonathan Z Li; Kelly B Arnold; Janet Lo; Anne-Sophie Dugast; Jill Plants; Heather J Ribaudo; Kevin Cesa; Andrea Heisey; Daniel R Kuritzkes; Douglas A Lauffenburger; Galit Alter; Alan Landay; Steven Grinspoon; Florencia Pereyra
Journal:  Open Forum Infect Dis       Date:  2015-01-13       Impact factor: 3.835

Review 9.  Eradication of HIV-1 from the macrophage reservoir: an uncertain goal?

Authors:  Wasim Abbas; Muhammad Tariq; Mazhar Iqbal; Amit Kumar; Georges Herbein
Journal:  Viruses       Date:  2015-03-31       Impact factor: 5.048

10.  Replication-competent noninduced proviruses in the latent reservoir increase barrier to HIV-1 cure.

Authors:  Ya-Chi Ho; Liang Shan; Nina N Hosmane; Jeffrey Wang; Sarah B Laskey; Daniel I S Rosenbloom; Jun Lai; Joel N Blankson; Janet D Siliciano; Robert F Siliciano
Journal:  Cell       Date:  2013-10-24       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.